Insiders · Profile

Rongen Roelof

Chief Executive Officer at Matinas BioPharma. Filing since 8 Sep 2017. CIK 0001698966

Company
Date
Role
Action
Shares
Amount
Of holding
8 Sep 2017
Chief Executive Officer
Bought
5,000
$6.80K
0.1%
1 decision on file.